NCT03812731

Brief Summary

The study is designed to explore any association between the caudal epidural block(CEB) given for perioperative analgesia and the occurrence of urethrocutaneous fistula postoperatively in children undergoing distal hypospadias repair .We also intend to study the duration of penile engorgement due to CEB causing penile oedema which may subsequently play a role in fistula formation. The pilot study will recruit children under 8 years of age diagnosed with distal hypospadias scheduled to undergo Tubularised Incised Plate Urethroplasty, operated by a single paediatric surgeon. General anaesthesia will be induced with sevoflurane in oxygen nitrous oxide mixture supplemented by fentanyl citrate and atracurium besylate in all children. LMA Pro SealTMof appropriate size will be inserted. Children in group I will then be given caudal epidural block (CEB) as per our practice protocol. Children in group II will be given additional intravenous fentanyl citrate. All children will be followed postoperatively till 3 months to evaluate incidence of urethtocutaneous fistula. The prospective study attempts to eliminate previously reported confounding factors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 23, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

February 22, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2019

Completed
Last Updated

October 30, 2020

Status Verified

October 1, 2020

Enrollment Period

9 months

First QC Date

January 19, 2019

Last Update Submit

October 29, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of urethrocutaneous fistula

    Patients undergoing distal hypospadias repair will be followed up for occurrence of uretherocutaneous fistula

    From one day after surgery(0-hours, baseline) till 3-months post surgery

Secondary Outcomes (5)

  • Penile Engorgement

    After induction of anaesthesia (0-hours, baseline) till end of surgery

  • Changes in intra-operative heart rate (beats per minute)

    From beginning of anesthesia (0-hours, baseline) till 2-hours intraoperatively

  • Change in Intra-operative blood pressure - systolic , diastolic, and mean (mmHg)

    rom beginning of anesthesia (0-hours, baseline) till 2-hours intraoperatively

  • Postoperative analgesia requirement

    From end of anaesthesia (0-hours, baseline) till 24-hours postoperatively

  • Incidence of complications

    From end of anaesthesia (0-hours, baseline) till 3-months postoperatively

Study Arms (2)

Caudal Group

ACTIVE COMPARATOR

Children will receive oral midazolam 0.25 mg/kg thirty minutes before induction. Inhalational induction will be carried with incremental concentration of sevoflurane upto 8% in 50% oxygen and nitrous oxide mixture. As soon as the child will be asleep, ASA standard monitors (SPO2, HR, ECG and NIBP) will be attached. Intravenous access with age appropriate IV cannula will be secured. Injection fentanyl citrate 2 mcg/ kg followed by injection atracurium 0.5 mg/kg will be administered. Appropriate size LMA Pro SealTM will be inserted and pressure controlled ventilation will be instituted. Children in will then receive CEB with 0.2 % ropivacaine 1-ml/kg for maintaining analgesia

Drug: Ropivacaine

Non- Caudal Group

ACTIVE COMPARATOR

Children will receive oral midazolam 0.25 mg/kg thirty minutes before induction. Inhalational induction will be carried with incremental concentration of sevoflurane upto 8% in 50% oxygen and nitrous oxide mixture. As soon as the child will be asleep, ASA standard monitors (SPO2, HR, ECG and NIBP) will be attached. Intravenous access with age appropriate IV cannula will be secured. Injection fentanyl citrate 2-mcg/ kg followed by injection atracurium 0.5 mg/kg will be administered. Appropriate size LMA Pro SealTM will be inserted and pressure controlled ventilation will be instituted. Children in will then receive fentanyl citrate 1-mcg/kg/hr for maintaining analgesia

Drug: Fentanyl Citrate

Interventions

Intraoperatively after induction of anaesthesia caudal epidural block will be administered with 0.2% ropivacaine 1-ml/kg

Caudal Group

Intraoperatively after induction of anaesthesia fentanyl 1-mcg/kg/hour will be administered

Non- Caudal Group

Eligibility Criteria

Age1 Year - 8 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsOnly male patients with distal hypospadias will be included
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Male children l
  • to 8 years of age
  • ASA physical status I and II
  • Distal hypospadias -

You may not qualify if:

  • Simultaneously undergoing any other procedure
  • Local infection in sacral region
  • Bleeding diathesis
  • Preoperative testosterone stimulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sir Ganga Ram Hospital

New Delhi, National Capital Territory of Delhi, 110060, India

Location

MeSH Terms

Interventions

RopivacaineFentanyl

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Deepali Shukla, DA

    Sir Ganga Ram Hospital

    PRINCIPAL INVESTIGATOR
  • Archna Koul, MS, MCH

    Sir Ganga Ram Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The attending anaesthesiologist will not be blinded to the technique utilised to administer GA. An independent assessor blinded to the technique of GA will follow up the patients to determine the incidence of uretherocutaneous fistula
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: 30 male patients aged 1-8 years, ASA physical status I/II, and undergoing distal hypospadias repair will be randomly allocated to one of the following two groups: GROUP I- (Caudal group, n= 15) Children will receive general anesthesia (GA) and analgesia will be maintained with caudal epidural block (CEB) with 0.2% ropivacaine:1 ml/kg. GROUP II- (Non-caudal group, n= 15) Children will receive general anaesthesia (GA) and analgesia will be maintained with intravenous fentanyl citrate 1mcg/kg/hr. roup-1 \[CLADS Group, n=60\]: Anaesthesia will be induced and maintained with propofol administered using the BIS feedback-based automated CLADS. Group-2 \[Desflurane Group, n=60\]: Anaesthesia will be induced with propofol CLADS and will be maintained intraoperatively by Desflurane titrated to BIS monitoring.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor & Consultant

Study Record Dates

First Submitted

January 19, 2019

First Posted

January 23, 2019

Study Start

February 22, 2019

Primary Completion

November 28, 2019

Study Completion

November 28, 2019

Last Updated

October 30, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations